Ionis Pharmaceuticals, Inc.
METHODS FOR REDUCING LRRK2 EXPRESSION
Last updated:
Abstract:
Provided herein are methods for decreasing LRRK2 mRNA expression. Such methods are useful to ameliorate LRRK2 associated diseases. Such LRRK2 associated diseases include Parkinson's Disease, including non-LRRK2 mediated Parkinson's Disease.
Status:
Application
Type:
Utility
Filling date:
17 Dec 2020
Issue date:
4 Nov 2021